Input is sought on federal plan to address adverse drug events

09/10/2013 |

HHS is seeking feedback on its draft National Action Plan for Adverse Drug Event Prevention, which aims to align the work of federal health agencies and recognize common, measurable, preventable and clinically significant adverse events related to medications. The initial focus will be on opioids, diabetes treatments and anticoagulants. Comments on the draft will be accepted until Oct. 3.

View Full Article in:

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Marlborough, MA
Test Technician
Marlborough, MA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
Ridgefield, CT